Changes in the GH IGF 1 axis with aging

Changes in the growth hormone (GH)–IGF-1 axis with aging

Aging is associated with a significant decline in the GH area under the curve, as well as the number and amplitude of night-time GH peaks. These changes in GH secretion (approximately 15% decline for every decade after age 30 years) are also associated with a steady decline in IGF-1 production. By age 65 years, most individuals have a serum IGF-1 concentration that is near or below the lower limit of normal for young healthy individuals. The observed decline in the GH–IGF-1 axis appears to occur above the level of the pituitary because chronic treatment with growth hormone–releasing hormone (GHRH) and/or other GH secretagogues (GHS) mitigates much of the decline. The cause of the fall-off in GH–IGF-1 axis activity is not clear but could be explained by age-related decreases in GHRH or ghrelin secretion, increased inhibition by somatostatin, increased sensitivity of somatotrophs to negative feedback inhibition by IGF-1, and/or a decline in pituitary responsiveness to GHRH or ghrelin. Ghrelin appears to be the natural ligand for the GHS receptor. Although there is a close physiologic relationship between GH secretion and slow-wave sleep, it is unclear if the altered GH–IGF-1 axis is the consequence or cause of profound age-related changes in sleep architecture.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top